glp-1 oral health news FDA approves Foundayo, an alternative to Wegovy and Ozempic Oral GLP-1 receptor agonists are

Apr 2026 Orforglipron (Foundayo), the first oral small-molecule GLP-1, wins approval for obesity in the fastest new-drug clearance since 2002

A) Fibrinogen B) Immunoglobulin G (IgG) C) Albumin D) 1-antitrypsin Answer: C) Albumin synthesized in the liver

Seidel HS, Smith TA, Evans JK, Stamper JQ, Mast TG, Kimble J (2018) C

Self-Reported Weight Loss in Pounds Shows GLP User Weight Loss is In Line with Other Weight Loss Methods Source: Citi Research The backdrop to the survey is that global obesity rates have steadily climbed in recent years

Therefore, education in the management of insulin doses is a crucial component of this therapy, both at initiation and during follow-up